Bediol - THC 6.3% | CBD 8%

Bediol - THC 6.3% | CBD 8%
Product Description

Introduced in 2007, Bediol® is the brand name for the cultivar Cannabis sativa L. ‘Elida’. Cannabis sativa L. ‘Elida’ is one of the first cannabis cultivars developed specifically to have a higher CBD content. The effects of CBD are distinctly different from THC. Bediol® has a balanced ratio of THC 6.3% and CBD 8%. Because it is easily tolerated, physicians often prescribe Bediol® for patients who previously have not used cannabis as a medicine. The ‘Elida’ cultivar was bred in-house by Bedrocan, specifically to meet the needs of patients. Bediol® is available in granular form.

Read more Show less

Bedrocan

  • NL
  • 2018
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Green Product; International Approvals/Standards; Product Features; Product Performance; Reputation
  • Supplied from
    Netherlands
More specifications Fewer specifications
Sales Markets
Show more Show less

Bedrocan

  • NL
  • 2018
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
View company profile

More Products from Bedrocan (2)

  • Bedrocan - THC 22% | CBD <1.0%

    Product Bedrocan - THC 22% | CBD <1.0%

    Introduced in 2003, Bedrocan® is  the brand name for the cultivar Cannabis sativa L. ‘Afina’. Cannabis sativa L. ‘Afina’ is the first cultivar developed and it features 22% THC, with a CBD-level below 1%. It’s the most widely used medicinal cannabis product and has been use...
  • Bedrolina®- THC 14% | CBD <1.0%

    Product Bedrolina®- THC 14% | CBD <1.0%

    Introduced in 2024, Bedrolina® Bedrolina® is the brand name for the indica cultivar Cannabis sativa L. ‘Janna’, and it is the most recent product launched in our portfolio. Cannabis sativa L. ‘Janna’ was developed to supply a product with higher CBD content that facilitat...

Bedrocan resources (2)

  • Bedrocan develops new practice for cannabis cultivation

    News Bedrocan develops new practice for cannabis cultivation

    Bedrocan has developed a new practice for medicinal cannabis cultivation. The practice is already in use at Bedrocan’s facilities and is called GMCCP: Good Medicinal Cannabis Cultivation Practice. According to Bedrocan, GACP is not sufficient for cannabis intended for medicinal use, hence the need for a special practice for the cultivation of medicinal cannabis.


    15 Sep 2022
  • Cannabis-based medicine and chronic pain

    Webinar Cannabis-based medicine and chronic pain

    Monique van Velzen is research manager, assistant professor and supervisor of medical researchers at the Anesthesiology department of the LUMC in Leiden, Netherlands. Her research focuses on understanding patients with (chronic) pain better and studying the most optimal form of pain relief. Since 2017, Monique has been supervising research into medicinal cannabis for specific types of pain. For more information about the webinars, visit www.bedrocan.com/series
    2022-06-13